Spinal cord stimulation with breathing training for long-term spinal cord injury
Tests stimulation through the skin plus breathing exercises in adults with long-standing spinal cord injury.
Key facts
- Who runs it
- University of Louisville
- Where
- Louisville, United StatesSee the site
- Trial code
- Registry title
- Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury
- Status
- Recruiting
- People taking part
- 36 people, planned
- Started
- 10 Sept 2023
- Expected to end
- 10 Apr 2030
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcutaneous spinal cord stimulator
- Respiratory Training
- Record updated
- 13 March 2026
Who can take part
The trial is looking for adults with a long-standing spinal cord injury that weakened their breathing. They will get breathing training, skin-surface spinal cord stimulation, or both.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Spinal cord injury at least 12 months before the study that is not getting worse. Motor-complete injury, AIS grade "A" or "B", above the T5 spinal level. Not dependent on a breathing machine. Stable medical condition.
- Biomarker or test result
- Breathing tests (FVC and FEV1 on spirometry) at least 15% below normal values for healthy people.
- Main reasons for not taking part
- Major lung or heart disease
- Needing a breathing machine (ventilator)
- Cancer, hormone (endocrine) disorders, marked obesity or deep vein thrombosis
- HIV/AIDS-related illness or low blood pressure from other causes
- Pregnant or planning to become pregnant during the study
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- At least 18 years old
- stable medical condition
- no painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore or urinary tract infection that might interfere with respiratory training or stimulation
- no clinically significant depression, psychiatric disorders or ongoing drug abuse
- non-progressive SCI (no negative change in the neurological level and motor-completeness assessed during screening when compared to the neurological status assessed at 6-mo period after injury or at least 6 months prior to the screening), non-ventilator dependence, motor-complete SCI according to the American Spinal Injury Association Impairment Scale (AIS) grade "A" or "B" above T5 spinal level
- sustained SCI at least 12 months prior to entering the study
- compared to the normative values for healthy population, at least 15%-deficit in pulmonary function outcomes (FVC and FEV1) as detected by screening spirometry
Who cannot take part
- major pulmonary or cardiovascular disease,
- endocrine disorders,
- malignancy,
- deep vein thrombosis,
- HIV/AIDS-related illness,
- secondary hypotension (anemia, hypervolemia, endocrine and neurological diseases),
- major esophageal/gastrointestinal problem or other major medical illness contraindicated for respiratory training or testing; During screening, the potential participant will be asked whether she is pregnant or planning to become pregnant during the study period. Pregnant women are excluded from this study, as the risk to the fetus is unknown. No pregnancy test or birth control regimen will be required
- Participants will be excluded from the study if there is a presence of
- ventilator dependence,
- marked obesity,
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Spinal cord injuries or respiration disorders
This trial is currently available in United States.
- Frazier Rehabilitation and Neuroscience InstituteLouisville, United StatesContact: Andrea Willhite, MSTaking people
About the trial
What the trial wants to find out
Respiratory complications are among the leading causes of death in patients with chronic spinal cord injury (SCI). Our previous work showed that pulmonary function can be improved by using our original respiratory training method. However, the effectiveness of this intervention is limited due to the disruption of brain-spinal connections and consequently lowered spinal cord activity below the injury level. Our recent studies showed that electrical stimulation of the spinal cord below the level of injury leads to increased ventilation which indicates activation of the spinal cord structures related to respiration. These findings indicate that spinal cord stimulation can be a promising therapeutic additive to the treatment. The goal of this study is to justify the establishment of a new direction in rehabilitation for patients with SCI by using a non-invasive spinal cord stimulation in combination with respiratory training.
Read full original descriptionShow less
Our aims are: 1) to evaluate the effects of such stimulation applied to the injured spinal cord on pulmonary function and respiratory muscle activity, and 2) to evaluate the effectiveness and therapeutic mechanisms of the spinal cord stimulation combined with respiratory training. Thirty-six individuals with chronic SCI will be recruited and assigned to three groups to receive respiratory training or spinal cord stimulation alone or a combination of them. All participants will be tested before and after cycles of experimental procedures with/or without stimulation. Our hypotheses will be confirmed if the respiratory training combined with spinal cord stimulation results in the most enhanced positive effects.
The 3 groups in the trial
- Training (RT) groupExisting treatment, for comparison
80 scTS sessions will be administered using the Neostim/Biostim (Cosyma Inc., Denver CO) device applying up to five conductive electrodes placed on the skin at the midline over the thoracic levels as cathodes between T1 to T8, and up to four self-adhesive electrodes located symmetrically on the skin over the iliac crests and shoulders as anodes. During the intervention, optimally configured scTS will be delivered based on the measures assessed during mapping sessions. The scTS with 5 mA-sub-motor threshold intensity with optimal frequency and pulse width will be delivered using 5 min on and 5 min off stimulation periods during interventional bouts. Every research participant will be slowly acclimated to stimulation. Blood pressure, heart rate, and respiratory rate will be closely monitored throughout stimulation sessions in the Lab by using beat-to-beat blood pressure, and respiratory kinematics monitoring.
Treatment: Respiratory Training
- Spinal Cord Transcutaneous Stimulation (scTS) groupExisting treatment, for comparison
Participants will undergo 80 RT sessions using standard threshold Positive Expiratory Pressure Device (PEP, Respironics Inc., Cedar Grove, NJ) and standard threshold Inspiratory Muscle Trainer (IMT, Respironics Inc., Cedar Grove, NJ) assembled together using a T-shaped connector with a flanged mouthpiece (Airlife 001504). Participants will be trained at the Frazier Rehab Institute and remotely to complete eighty 45-minute sessions during 16 weeks. The participants will be instructed to perform inspiratory and expiratory efforts against a pressure threshold load. The training will be initiated with a load equal to 20% of their individual Maximum Inspiratory Pressure (PImax) and Maximum Expiratory Pressure (PEmax) values with progressive increases as tolerated up to 60% of their baseline PImax and PEmax measures. The goal will be to reach the 60% load of PImax and PEmax during the last week of each month of the training.
Treatment: Transcutaneous spinal cord stimulator
- Spinal Cord Transcutaneous Stimulation and Respiratory Training (scTS+RT) groupTreatment being tested
Participants will undergo 80 scTS combined with the RT while seated in their own wheelchairs with an approximately 45° head-up tilt. The scTS will be administered using the Neostim/Biostim (Cosyma Inc., Denver CO) and Standard threshold Positive Expiratory Pressure Device (PEP, Respironics Inc., Cedar Grove, NJ) and standard threshold Inspiratory Muscle Trainer (IMT, Respironics Inc., Cedar Grove, NJ) assembled together using a T-shaped connector with a flanged mouthpiece (Airlife 001504) will be used for the RT as described for the Arms 1 and 2.
Treatment: Transcutaneous spinal cord stimulator and Respiratory Training
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neuromodulatory Rehabilitation for Respiratory Motor Function in Individuals With Chronic Spinal Cord Injury
- Plain-language title
- Spinal cord stimulation with breathing training for long-term spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06019949, who can take part
- Record updated
- 13 March 2026